Anaplastic Large-Cell Lymphoma (KM Lymphoma) with Expression of IL-5 mRIMA and Eosinophilic Invasion

Acta Haematologica

Volumn 96, Issue 4, 1996, Pages 245-248

  Takimoto, Yasuo ^a   Tanaka, Hideo ^a   Tanabe, Osamu ^a   Kuramoto, Aisushi ^a   Sasaki, Naomi ^b   Nanba, KÔji ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kure Mutual Aid Hospital   (Japan)

Author keywords

Anaplastic large cell lymphoma; Eosinophilia; IL 5

Indexed keywords

INTERLEUKIN 5; MESSENGER RNA;

ADULT; ARTICLE; BLOOD; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MALE; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EOSINOPHILIA; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-5; LYMPHOMA, LARGE-CELL, KI-1; MALE; PREDNISOLONE;

EID: 0029848571     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203793     Document Type: Article

References (22)

1. Fuggle WJ, Crocker J, Smith PJ: A quantitative study of eosinophil polymorphs in Hodgkin’s disease. J Clin Pathol 1984;37:267-271.
2. Greer JP, York JC, Cousar JB, Mitchell RT, Flcxner JM, Collins RD, Stein RS: Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. J Clin Oncol 1984;2:788-798.
3. Vukelja SJ, Weiss RB, Perry' PJ, Longo DL: Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer 1988;62:1527-1530.
4. Murata K, Yamada Y. Kamihira S, Atogami S, Tsukasaki K, Momita S, Amagasaki T, Sada-mori N, Tomonaga M, Kinoshita K, Ichima-ru M: Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992;69: 966-971.
5. Spitzer G, Garson DH: Lymphoblastic leukemia with marked eosinophilia: A report of two cases. Blood 1973;42:377-384.
6. Takimoto Y, Tanaka H, Tanabe O, Kuramoto A, Sasaki N, Nanba K: A patient with anaplastic large cell lymphoma (ki-1 lymphoma) showing clonal integration of HTLV-1 proviral DNA. Leukemia 1994;8:507-509.
7. Hayashida K, Kitamura T, Gorman DM. Arai K, Yokota T, Miyajima A: Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 1990;87:9655-9659.
8. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A: Recombinant human interleukin 5 is a selective eosinophil che-moattractant. Eur J Immunol 1989; 19:701-705.
9. Enokihara H. Furusawa S, Nakakubo H, Kiji-tani H, Nagashima S, Saito K, Shishido H. Hitoshi Y, Takatsu K. Noma T, Shimizu A, Honjo T: T cells from eosinophilic patients produce interleukin-5 with intcrleukin-2 stimulation. Blood 1989;73:1809-1813.
10. Samoszuk M, Nansen L: Detection of intcrlcu-kin-5 messenger RNA in Reed-Stemberg cells of Hodgkin’s disease with eosinophilia. Blood 1990;75:13-16.
11. Meeker TC, Hardy D. Willman C, Hogan T. Abrams J: Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood 1990; 76:285-289.
12. Borish L, Dishuck J, Cox L, Mascali JJ, Williams J, Roscnwasscr LJ: Sczary syndrome with elevated serum IgE and hypereosinophilia: Role of dysregulated cytokine production. J Allergy Clin Immunol 1993;92:123-131.
13. Samoszuk M, Ramzi E, Cooper DL: Intcrlcu-kin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol 1993:42:402-404.
14. Fermand JP, Mitjavila MT, Lc Coucdic JP, Tsapis A, Berger R, Modigliani R, Seligmann M, Brouct JC, Vainchenker W: Role of granulocyte-macrophage colony stimulating factor, intcrleukin-3 and intcrlcukin-5 in the cosino-philia associated with T cell lymphoma. Br J Haematol 1993;83:359-364.
15. Navarron-Roman L, Medeiros LJ, Kingma DW, Zerate-Osorno A, Nguyen V, Samoszuk M, Jaffc ES: Malignant lymphomas of B cell lineage with marked tissue eosinophilia. A report of five cases. Am J Surg Pathol 1994; 18: 347-356.
16. Kancko Y, Frizzcra G, Edamura S. Maseki N, Sakurai M, Kamada Y, Sakurai M, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S: A novel translocation, t(2;5) (p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989;73:806-813.
17. Fisher P. Nacheva E. Mason DY, Sherrington PD, Hoyle C, Hayhoe FGJ, Karpas A: A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin’s lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor p-chain gene. Blood 1988;72:234-240.
18. Rimokh R, Magaud J-P, Berger F. Samarut J, Coiflfier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘ki-1 lymphoma’). Br J Haematol 1989;71:31-36.
19. Fonatsch C, Latza U, Diirkop H, Rieder H, Stein H: Assignment of the human CD30 (ki-1) gene to lp36. Genomics 1992;14:825-826.
20. Diirkop H. Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992;68:421-427.
21. Diirkop H. Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992;68:421-427.
22. Newcom SR, Tagra KK, Kadin ME: Neutralizing antibodies against transforming growth fac-tor-p potentiate the proliferation of ki-1 positive lymphoma cells: Further evidence for negative autocrine regulation by transforming growth factor-p. Am J Pathol 1992; 140:709-718.